Synchronous ovarian dysgerminoma and metastatic breast carcinoma: A case report
Abstract
Introduction: Synchronous dual malignancies are rare findings. A unique case report of first of its kind of synchronous ovarian dysgerminoma and metastatic infiltrating duct carcinoma of the breast is being reported.
Presentation of Case: A young female investigated for pain abdomen was found to have right ovarian mass was operated outside which was histopathologically proven to be dysgerminoma presented to our clinics with complaints of a bilateral breast lump, dry cough and pain abdomen. She had a raised beta HCG and LDH. She was investigated and diagnosed as a case of metastatic breast carcinoma with ovarian dysgerminoma.
Discussion: Patients with germline BRCA mutations have been shown to present with such aggressive dual malignancy of breast and ovary. She survived only for two to three months after her initial presentation.
Conclusion: Such patients need to be screened and detected early so that aggressive treatment could be started and survival could be increased.
Downloads
References
Suzuki T, Takahashi H, Yao K, Inagi K, Nakayama M, Makoshi T, et al. Multiple primary malignancies in the head and neck: a clinical review of 121 patients. Acta Otolaryngol Suppl. 2002; (547):88- 92
Cojan TTS, Vidrighin CD, Ciobanu M, Pauni I, Teodorescu M, Mogos G, et al. Breast-conserving surgery in breast cancer. Chirurgia (Bucur). 2012;107(5):616-25.
Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61(4): 212-36.
Bordea C, Plesca M, Condrea I, Gherghe M, Gociman A, Blidaru A. Occult breast lesion localization and concomitant sentinel lymph node biopsy in early breast cancer (SNOLL). Chirurgia (Bucur). 2012;107(6):722-9
Smith HO, Berwick M, Verschraegen CF et al. Incidence and survival rates for female malignant germ cell tumors. Obstet Gynecol 2006;107(5): 1075–1085.
Bidus MA, Elkas JC, Rose GS. Germ cell,stromal, and other ovarian tumors. In: Di Saia PJ, Creasman WT, eds. Clinical gynecologic oncology. 8th ed. Philadelphia, Pa: Elsevier/Saunders, 2012;329–356. Crossref, Google Scholar
Pauniaho SL, Salonen J, Helminen M, Vettenranta K, Heikinheimo M, Heikinheimo O. The incidences of malignant gonadal and extragonadal germ cell tumors in males and females: a population-based study covering over 40 years in Finland. Cancer Causes Control 2012;23(12):1921–1927. Crossref, Medline, Google Scholar
Siegel RL, Miller KD, Jemal A: Cancer statistics, 2019: CA Cancer J Clin. 2019, 69:7-34. 10.3322/caac.21551
Arrangoiz R, Papavasiliou P, Dushkin H, Farma JM: Case report and literature review: metastatic lobular carcinoma of the breast an unusual presentation. Int J Surg Case Rep. 2011,2:301-305. 10.1016/j.ijscr.2011.06.010
Sheen-Chen SM, Liu YW, Sun CK, Lin SE, Eng HL, Huang WT, Ko SF: Abdominal carcinomatosis attributed to metastatic breast carcinoma. Dig Dis Sci. 2008, 53:3043-3045.10.1007/s10620-008-0529-y
Eeles RA. Screening for hereditary cancer and genetic testing, epitomized by breast cancer. Eur J Cancer. 1999;35(14):1954-62.
Cannistra, S. A., D. M. Gershenson, et al. (2005). "Ovarian Cancer, Fallopian Tube Carcinoma, and Peritoneal Carcinoma." In V. T. DeVita, T. S. Lawrence, S. A. Rosenberg, eds. Devita, Hellman & Rosenberg's Cancer: Principles & Practice of Oncology, 8th ed. Lippincott Williams and Wilkins; Philadelphia, PA 4(5): 1587-
Talerman, A. (2002). "Germ cell tumors of the ovary." In R. J. Kurman, ed. Blaustein's Pathology of the Female Genital Tract, 5th ed. Springer-Verlag; New York, NY: 967- 1034.
Ramesh, H., M. Philip, et al. (2001). "Isolated duodenal-pancreatic involvement due to metastatic dysgerminoma ovary and its management by a modified pancreaticoduodenal resection." Dig Surg 18(6): 479-482.
Pendergrass, E. P. and J. Selman (1946). "Dysgerminoma of the ovary with widespread metastases." Radiology 46: 377-379.
Mandeville, F. B., P. F. Sahyoun, et al. (1949). "Dysgerminoma of the ovary in a 4-year-old girl with metastases clinically simulating Wilms' tumor and adrenal neuroblastoma." J Pediatr 34(1): 70-75.
Zaloudek, C. J. (2011). "Pathology of Germ Cell Tumors." In R. A. Soslow and C. Tornos, eds. Diagnostic Pathology of Ovarian Tumors. Springer; New York, NY: 155-191
Zhao, Y., Y. Li. (2003). "Clinicopathological significance of plap, NSE and WT1 detection in ovarian dysgerminoma." Chin J Can Res 15(2): 136-139.
Bertozzi S, Londero AP, Cedolini C, et al.: Prevalence, risk factors, and prognosis of peritoneal metastasis from breast cancer. SpringerPlus. 2015, 4:688.
Flanagan M, Solon J, Chang KH, et al.: Peritoneal metastases from extra-abdominal cancer – a population-based study. Eur J Surg Oncol. 2018, 44:1811-1817
Loman N, Johannsson O, Kristoffersson U, Olsson H, Borg A. Family history of breast and ovarian cancers and BRCA1 and BRCA2 mutations in a population-based series of early-onset breast cancer. J Natl Cancer Inst. 2001;93(16):1215-23.
Rubin SC, Benjamin I, Behbakht K, Takahashi H, Morgan MA, LiVolsi VA, et al. Clinical and pathological features of ovarian cancer in women with germ-line mutations of BRCA1. N Engl J Med. 1996;335(19):1413-6
Jóhannsson OT, Ranstam J, Borg A, Olsson H. Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden. J Clin Oncol. 1998;16(2):397-404
Werness BA, Ramus SJ, Whittemore AS, Garlinghouse-Jones K, Oakley-Girvan I, DiCioccio RA, et al. Primary ovarian dysgerminoma in a patient with a germline BRCA1 mutation. Int J Gynecol Pathol. 2000;19(4):390-4.
